CAS 1562338-42-4
:Lmi 070
Description:
Lmi 070, identified by its CAS number 1562338-42-4, is a chemical compound that has garnered attention in various research contexts, particularly in the field of medicinal chemistry. While specific characteristics such as its molecular structure, physical properties, and reactivity may not be widely documented in public databases, compounds like Lmi 070 are often evaluated for their biological activity, stability, and potential applications in pharmaceuticals or agrochemicals. Typically, such substances may exhibit unique functional groups that contribute to their reactivity and interaction with biological systems. Researchers may investigate its solubility, melting point, and spectral properties to understand its behavior in different environments. Additionally, safety data sheets would provide crucial information regarding its handling, toxicity, and environmental impact. For precise applications and characteristics, consulting specialized literature or databases focused on chemical substances is recommended, as they may provide detailed insights into Lmi 070's specific uses and properties.
Formula:C22H27N5O2
InChI:InChI=1S/C22H27N5O2/c1-21(2)10-16(11-22(3,4)27-21)29-20-8-7-18(25-26-20)17-6-5-14(9-19(17)28)15-12-23-24-13-15/h5-9,12-13,16,27-28H,10-11H2,1-4H3,(H,23,24)
InChI key:InChIKey=STWTUEAWRAIWJG-UHFFFAOYSA-N
SMILES:OC1=C(C=CC(=C1)C=2C=NNC2)C3=CC=C(OC4CC(C)(C)NC(C)(C)C4)N=N3
Synonyms:- NVS-SM1, Branaplam
- NVS-SM1
- LMI070 (Branaplam)
- NVS-SM1; LMI-070;
- Branaplam
- 5-(1H-pyrazol-4-yl)-2-(6-((2,2,6,6-tetramethylpiperidin-4-yl)oxy)pyridazin-3-yl)phenol
- LMI070 (NVS-SM1)
- Phenol, 5-(1H-pyrazol-4-yl)-2-[6-[(2,2,6,6-tetramethyl-4-piperidinyl)oxy]-3-pyridazinyl]-
- LMI 070;LMI-070;LMI070
- LMI070
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
5-(1H-Pyrazol-4-Yl)-2-(6-((2,2,6,6-Tetramethylpiperidin-4-Yl)Oxy)Pyridazin-3-Yl)Phenol
CAS:5-(1H-Pyrazol-4-Yl)-2-(6-((2,2,6,6-Tetramethylpiperidin-4-Yl)Oxy)Pyridazin-3-Yl)PhenolPurity:98%Molecular weight:393.48g/molBranaplam
CAS:<p>Branaplam (LMI 070) is a highly potent, selective and orally active small molecule SMN2 splicing modulator.</p>Formula:C22H27N5O2Purity:98.28% - 99.72%Color and Shape:SolidMolecular weight:393.48Branaplam
CAS:Branaplam is a small-molecule drug that binds to the messenger RNA of the enzyme protein kinase C (PKC) and inhibits its activity. It has been shown to be effective in treating PKC-dependent diseases, such as cancer and autoimmune disorders. Branaplam is also used for the diagnosis of PKC-dependent diseases by detecting PKC mRNA levels in cells or tissues. This compound can be used for the treatment of human patients with PKC-dependent diseases, including cancer, rheumatoid arthritis, multiple sclerosis, and asthma.Formula:C22H27N5O2Purity:Min. 98 Area-%Color and Shape:PowderMolecular weight:393.48 g/mol



